SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-18-000033
Filing Date
2018-08-03
Accepted
2018-08-02 17:55:14
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q032018.htm 10-Q 883321
2 exhibit10_2.htm EX-10.2 56061
3 exhibit10_3.htm EX-10.3 49430
4 exhitbit10_4.htm EX-10.4 56516
5 exhibit10_5.htm EX-10.5 36231
6 ex12.htm EX-12 57072
7 exhibit31_1.htm EX-31 12886
8 exhibit31_2.htm EX-31 12516
9 exhibit32_1.htm EX-32 3326
10 exhibit32_2.htm EX-32 3370
  Complete submission text file 0001367644-18-000033.txt   3909146

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT ebs-20180630.xml EX-101.INS 498130
12 XBRL TAXONOMY EXTENSION SCHEMA ebs-20180630.xsd EX-101.SCH 33064
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20180630_cal.xml EX-101.CAL 68246
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20180630_def.xml EX-101.DEF 155205
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20180630_lab.xml EX-101.LAB 476282
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20180630_pre.xml EX-101.PRE 284699
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 18989785
SIC: 2834 Pharmaceutical Preparations